Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

492
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
492
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

488
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
488
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

433
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
433
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

521
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
521
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

321
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
321
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

361
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Detection in Traffic-Related Fatalities in Connecticut (2020-2024).

Journal of analytical toxicology·2026
Same author

The "Value-Added" Death Certificate.

The American journal of forensic medicine and pathology·2025
Same author

The evolution of postmortem investigation: a historical perspective on autopsy's decline and imaging's role in its revival.

Frontiers in radiology·2025
Same author

Fatal Hip Fractures From Accidental Falls From a Ground-Level Fall.

Academic forensic pathology·2025
Same author

A Survey of Forensic Pathologists Regarding Medicolegal Investigation of Perinatal and Stillborn Deaths.

The American journal of forensic medicine and pathology·2025
Same author

Forensic Pathologist Testimony, Part 2: Special Issues and Considerations.

Academic forensic pathology·2024

Related Experiment Video

Updated: Jan 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K

Diabetic Cardiomyopathy: A Forensic Perspective.

Angela R McGuire1, James R Gill1

  • 1Connecticut Office of the Chief Medical Examiner.

Academic Forensic Pathology
|June 27, 2019
PubMed
Summary
This summary is machine-generated.

Diabetic cardiomyopathy is a heart condition linked to diabetes, causing heart failure even without traditional risk factors like coronary artery disease. Understanding its molecular basis is key to addressing cardiac mortality in diabetic patients.

Keywords:
Cardiac hypertrophyCardiomyopathyCardiovascular diseaseDiabetes mellitusForensic pathology

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

611
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

18.2K

Related Experiment Videos

Last Updated: Jan 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

611
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

18.2K

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Diabetes mellitus is a prevalent condition with significant cardiovascular complications.
  • Long-standing diabetes is linked to atherosclerosis, hypertension, kidney disease, and heart failure.
  • Diabetic cardiomyopathy, heart failure in diabetics without other causes, contributes to cardiac mortality.

Purpose of the Study:

  • To explore the pathophysiology of diabetic cardiomyopathy.
  • To understand the molecular and metabolic alterations underlying this condition.

Main Methods:

  • Review of existing literature on diabetes and cardiovascular complications.
  • Analysis of molecular and metabolic pathways implicated in diabetic cardiomyopathy.

Main Results:

  • Diabetic cardiomyopathy is recognized as a distinct entity contributing to heart failure in diabetic patients.
  • Molecular and metabolic changes are central to its development.

Conclusions:

  • Diabetic cardiomyopathy is a significant cause of heart failure and mortality in diabetes.
  • Further research into its molecular pathophysiology is warranted to develop targeted therapies.